Annual CFO:
-$157.78M-$50.49M(-47.06%)Summary
- As of today, CLDX annual cash from operations is -$157.78 million, with the most recent change of -$50.49 million (-47.06%) on December 31, 2024.
- During the last 3 years, CLDX annual cash from operations has fallen by -$96.87 million (-159.04%).
- CLDX annual cash from operations is now -684.36% below its all-time high of $27.00 million, reached on December 31, 2006.
Performance
CLDX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$44.01M+$10.37M(+19.07%)Summary
- As of today, CLDX quarterly cash from operations is -$44.01 million, with the most recent change of +$10.37 million (+19.07%) on June 30, 2025.
- Over the past year, CLDX quarterly cash from operations has dropped by -$14.68 million (-50.05%).
- CLDX quarterly cash from operations is now -218.66% below its all-time high of $37.09 million, reached on March 31, 2006.
Performance
CLDX Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$186.19M-$14.68M(-8.56%)Summary
- As of today, CLDX TTM cash from operations is -$186.19 million, with the most recent change of -$14.68 million (-8.56%) on June 30, 2025.
- Over the past year, CLDX TTM cash from operations has dropped by -$64.70 million (-53.25%).
- CLDX TTM cash from operations is now -630.23% below its all-time high of $35.12 million, reached on March 31, 2006.
Performance
CLDX TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CLDX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -47.1% | -50.0% | -53.3% |
| 3Y3 Years | -159.0% | -97.8% | -139.7% |
| 5Y5 Years | -239.9% | -292.1% | -303.1% |
CLDX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -159.0% | at low | -131.7% | +20.5% | -93.0% | at low |
| 5Y | 5-Year | -290.5% | at low | -744.5% | +20.5% | -360.8% | at low |
| All-Time | All-Time | -684.4% | at low | -218.7% | +20.5% | -630.2% | at low |
CLDX Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$44.01M(+19.1%) | -$186.19M(-8.6%) |
| Mar 2025 | - | -$54.37M(-67.4%) | -$171.51M(-8.7%) |
| Dec 2024 | -$157.78M(-47.1%) | -$32.48M(+41.3%) | -$157.78M(+0.0%) |
| Sep 2024 | - | -$55.34M(-88.7%) | -$157.84M(-29.9%) |
| Jun 2024 | - | -$29.33M(+27.8%) | -$121.49M(-1.8%) |
| Mar 2024 | - | -$40.64M(-24.9%) | -$119.36M(-11.2%) |
| Dec 2023 | -$107.29M(-3.4%) | -$32.53M(-71.3%) | -$107.29M(-11.2%) |
| Sep 2023 | - | -$18.99M(+30.2%) | -$96.52M(+14.4%) |
| Jun 2023 | - | -$27.20M(+4.8%) | -$112.72M(-4.6%) |
| Mar 2023 | - | -$28.57M(-31.3%) | -$107.77M(-3.9%) |
| Dec 2022 | -$103.73M(-70.3%) | -$21.76M(+38.2%) | -$103.73M(-7.5%) |
| Sep 2022 | - | -$35.19M(-58.2%) | -$96.49M(-24.2%) |
| Jun 2022 | - | -$22.24M(+9.3%) | -$77.67M(-15.3%) |
| Mar 2022 | - | -$24.53M(-68.9%) | -$67.36M(-10.6%) |
| Dec 2021 | -$60.91M(-50.7%) | -$14.52M(+11.3%) | -$60.91M(-18.0%) |
| Sep 2021 | - | -$16.37M(-37.2%) | -$51.60M(-9.6%) |
| Jun 2021 | - | -$11.93M(+34.0%) | -$47.09M(-1.5%) |
| Mar 2021 | - | -$18.08M(-247.0%) | -$46.38M(-14.8%) |
| Dec 2020 | -$40.40M(+13.0%) | -$5.21M(+56.1%) | -$40.40M(+12.5%) |
| Sep 2020 | - | -$11.86M(-5.7%) | -$46.19M(-1.6%) |
| Jun 2020 | - | -$11.22M(+7.3%) | -$45.47M(-0.4%) |
| Mar 2020 | - | -$12.11M(-10.1%) | -$45.29M(+2.4%) |
| Dec 2019 | -$46.41M(+38.3%) | -$11.00M(+1.3%) | -$46.41M(+8.7%) |
| Sep 2019 | - | -$11.14M(-0.9%) | -$50.84M(+6.0%) |
| Jun 2019 | - | -$11.04M(+16.6%) | -$54.09M(+10.5%) |
| Mar 2019 | - | -$13.23M(+14.2%) | -$60.45M(+19.7%) |
| Dec 2018 | -$75.23M(+24.7%) | -$15.43M(-7.2%) | -$75.23M(+5.2%) |
| Sep 2018 | - | -$14.39M(+17.3%) | -$79.33M(+11.2%) |
| Jun 2018 | - | -$17.39M(+37.9%) | -$89.30M(+3.7%) |
| Mar 2018 | - | -$28.02M(-43.5%) | -$92.69M(+7.2%) |
| Dec 2017 | -$99.93M(+11.6%) | -$19.52M(+19.9%) | -$99.93M(+0.8%) |
| Sep 2017 | - | -$24.36M(-17.2%) | -$100.76M(-0.4%) |
| Jun 2017 | - | -$20.79M(+41.0%) | -$100.35M(+11.5%) |
| Mar 2017 | - | -$35.26M(-73.3%) | -$113.40M(-0.3%) |
| Dec 2016 | -$113.04M(-14.3%) | -$20.35M(+15.1%) | -$113.04M(-6.2%) |
| Sep 2016 | - | -$23.95M(+29.2%) | -$106.43M(+3.5%) |
| Jun 2016 | - | -$33.83M(+3.1%) | -$110.27M(-9.0%) |
| Mar 2016 | - | -$34.90M(-153.9%) | -$101.20M(-2.3%) |
| Dec 2015 | -$98.89M(+2.6%) | -$13.74M(+50.5%) | -$98.89M(+7.9%) |
| Sep 2015 | - | -$27.79M(-12.2%) | -$107.36M(-1.1%) |
| Jun 2015 | - | -$24.76M(+24.0%) | -$106.16M(-3.8%) |
| Mar 2015 | - | -$32.59M(-46.7%) | -$102.25M(-0.7%) |
| Dec 2014 | -$101.54M(-50.0%) | -$22.21M(+16.5%) | -$101.54M(-7.7%) |
| Sep 2014 | - | -$26.59M(-27.5%) | -$94.28M(-10.7%) |
| Jun 2014 | - | -$20.86M(+34.6%) | -$85.14M(-3.4%) |
| Mar 2014 | - | -$31.88M(-113.1%) | -$82.34M(-21.7%) |
| Dec 2013 | -$67.67M(-35.9%) | -$14.96M(+14.3%) | -$67.67M(-2.5%) |
| Sep 2013 | - | -$17.45M(+3.3%) | -$66.04M(-10.9%) |
| Jun 2013 | - | -$18.06M(-5.0%) | -$59.53M(-11.4%) |
| Mar 2013 | - | -$17.20M(-29.1%) | -$53.43M(-7.3%) |
| Dec 2012 | -$49.78M(-39.6%) | -$13.33M(-21.8%) | -$49.78M(-8.6%) |
| Sep 2012 | - | -$10.94M(+8.5%) | -$45.83M(-6.7%) |
| Jun 2012 | - | -$11.96M(+11.8%) | -$42.94M(-6.4%) |
| Mar 2012 | - | -$13.55M(-44.6%) | -$40.35M(-13.1%) |
| Dec 2011 | -$35.66M(-17.4%) | -$9.37M(-16.3%) | -$35.66M(-10.4%) |
| Sep 2011 | - | -$8.06M(+13.9%) | -$32.30M(-1.0%) |
| Jun 2011 | - | -$9.37M(-5.7%) | -$31.99M(+1.0%) |
| Mar 2011 | - | -$8.86M(-47.4%) | -$32.30M(-6.3%) |
| Dec 2010 | -$30.37M(-1.7%) | -$6.01M(+22.3%) | -$30.37M(+13.7%) |
| Sep 2010 | - | -$7.74M(+20.0%) | -$35.20M(-6.8%) |
| Jun 2010 | - | -$9.68M(-39.4%) | -$32.96M(-5.4%) |
| Mar 2010 | - | -$6.94M(+36.0%) | -$31.26M(-4.7%) |
| Dec 2009 | -$29.87M(-263.4%) | -$10.84M(-97.0%) | -$29.87M(-68.5%) |
| Sep 2009 | - | -$5.50M(+31.0%) | -$17.73M(+16.4%) |
| Jun 2009 | - | -$7.97M(-43.6%) | -$21.21M(-224.5%) |
| Mar 2009 | - | -$5.55M(-528.6%) | $17.04M(-6.8%) |
| Dec 2008 | $18.28M(+194.7%) | $1.29M(+114.4%) | $18.28M(+429.9%) |
| Sep 2008 | - | -$8.98M(-129.7%) | $3.45M(-70.0%) |
| Jun 2008 | - | $30.27M(+802.9%) | $11.50M(+154.4%) |
| Mar 2008 | - | -$4.31M(+68.2%) | -$21.14M(-9.5%) |
| Dec 2007 | -$19.30M | -$13.54M(-1351.6%) | -$19.30M(-149.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2007 | - | -$932.50K(+60.6%) | -$7.74M(+27.5%) |
| Jun 2007 | - | -$2.36M(+4.3%) | -$10.67M(+15.0%) |
| Mar 2007 | - | -$2.47M(-25.2%) | -$12.56M(-146.5%) |
| Dec 2006 | $27.00M(+548.8%) | -$1.97M(+48.9%) | $27.00M(-13.0%) |
| Sep 2006 | - | -$3.86M(+9.1%) | $31.05M(+1.3%) |
| Jun 2006 | - | -$4.25M(-111.5%) | $30.66M(-12.7%) |
| Mar 2006 | - | $37.09M(+1688.2%) | $35.12M(+683.6%) |
| Dec 2005 | -$6.02M(+41.9%) | $2.07M(+148.8%) | -$6.02M(+48.2%) |
| Sep 2005 | - | -$4.25M(-2139.3%) | -$11.63M(-12.0%) |
| Jun 2005 | - | $208.60K(+105.2%) | -$10.38M(+15.1%) |
| Mar 2005 | - | -$4.05M(-14.4%) | -$12.24M(-18.3%) |
| Dec 2004 | -$10.35M(+11.9%) | -$3.54M(-17.4%) | -$10.35M(-2.5%) |
| Sep 2004 | - | -$3.01M(-83.1%) | -$10.10M(-3.0%) |
| Jun 2004 | - | -$1.64M(+23.7%) | -$9.80M(+9.4%) |
| Mar 2004 | - | -$2.16M(+34.3%) | -$10.82M(+7.8%) |
| Dec 2003 | -$11.74M(+29.5%) | -$3.28M(-20.7%) | -$11.74M(-25.1%) |
| Sep 2003 | - | -$2.72M(-2.4%) | -$9.38M(+20.6%) |
| Jun 2003 | - | -$2.66M(+13.6%) | -$11.82M(+17.5%) |
| Mar 2003 | - | -$3.08M(-231.9%) | -$14.33M(+14.0%) |
| Dec 2002 | -$16.66M(+20.0%) | -$927.10K(+82.0%) | -$16.66M(+21.4%) |
| Sep 2002 | - | -$5.16M(+0.0%) | -$21.20M(+2.7%) |
| Jun 2002 | - | -$5.16M(+4.6%) | -$21.79M(-3.9%) |
| Mar 2002 | - | -$5.41M(+1.0%) | -$20.97M(-0.7%) |
| Dec 2001 | -$20.83M(-369.9%) | -$5.47M(+5.0%) | -$20.83M(-33.1%) |
| Sep 2001 | - | -$5.75M(-32.6%) | -$15.65M(-26.1%) |
| Jun 2001 | - | -$4.34M(+17.7%) | -$12.41M(-13.9%) |
| Mar 2001 | - | -$5.27M(-1734.8%) | -$10.90M(-145.9%) |
| Dec 2000 | -$4.43M(+48.1%) | -$287.20K(+88.6%) | -$4.43M(+18.4%) |
| Sep 2000 | - | -$2.52M(+11.0%) | -$5.43M(-2.3%) |
| Jun 2000 | - | -$2.83M(-336.2%) | -$5.31M(-7.1%) |
| Mar 2000 | - | $1.20M(+193.0%) | -$4.96M(+41.9%) |
| Dec 1999 | -$8.54M(+3.5%) | -$1.29M(+46.2%) | -$8.54M(-3.1%) |
| Sep 1999 | - | -$2.39M(+3.2%) | -$8.28M(+14.5%) |
| Jun 1999 | - | -$2.47M(-3.9%) | -$9.68M(-3.3%) |
| Mar 1999 | - | -$2.38M(-131.3%) | -$9.37M(-5.9%) |
| Dec 1998 | -$8.85M(-15.0%) | -$1.03M(+72.9%) | -$8.85M(+10.8%) |
| Sep 1998 | - | -$3.80M(-75.5%) | -$9.92M(-22.1%) |
| Jun 1998 | - | -$2.16M(-16.2%) | -$8.13M(-8.9%) |
| Mar 1998 | - | -$1.86M(+11.3%) | -$7.46M(+3.1%) |
| Dec 1997 | -$7.70M(+20.5%) | -$2.10M(-5.0%) | -$7.70M(-2.7%) |
| Sep 1997 | - | -$2.00M(-33.3%) | -$7.50M(+6.3%) |
| Jun 1997 | - | -$1.50M(+28.6%) | -$8.00M(+12.1%) |
| Mar 1997 | - | -$2.10M(-10.5%) | -$9.10M(+6.2%) |
| Dec 1996 | -$9.68M(-21.7%) | -$1.90M(+24.0%) | -$9.70M(-40.6%) |
| Sep 1996 | - | -$2.50M(+3.8%) | -$6.90M(+10.4%) |
| Jun 1996 | - | -$2.60M(+3.7%) | -$7.70M(-2.7%) |
| Mar 1996 | - | -$2.70M(-400.0%) | -$7.50M(+5.1%) |
| Dec 1995 | -$7.95M(+12.9%) | $900.00K(+127.3%) | -$7.90M(+31.3%) |
| Sep 1995 | - | -$3.30M(-37.5%) | -$11.50M(-12.7%) |
| Jun 1995 | - | -$2.40M(+22.6%) | -$10.20M(0.0%) |
| Mar 1995 | - | -$3.10M(-14.8%) | -$10.20M(-12.1%) |
| Dec 1994 | -$9.12M(-65.8%) | -$2.70M(-35.0%) | -$9.10M(-23.0%) |
| Sep 1994 | - | -$2.00M(+16.7%) | -$7.40M(-12.1%) |
| Jun 1994 | - | -$2.40M(-20.0%) | -$6.60M(-11.9%) |
| Mar 1994 | - | -$2.00M(-100.0%) | -$5.90M(-7.3%) |
| Dec 1993 | -$5.50M(-41.0%) | -$1.00M(+16.7%) | -$5.50M(-22.2%) |
| Sep 1993 | - | -$1.20M(+29.4%) | -$4.50M(+6.3%) |
| Jun 1993 | - | -$1.70M(-6.3%) | -$4.80M(-14.3%) |
| Mar 1993 | - | -$1.60M(-6.7%) | -$4.20M(+4.5%) |
| Dec 1992 | -$3.90M(+4.9%) | - | - |
| Oct 1992 | - | -$1.50M(-36.4%) | -$4.40M(0.0%) |
| Jul 1992 | - | -$1.10M(+15.4%) | -$4.40M(-7.3%) |
| Apr 1992 | - | -$1.30M(-160.0%) | -$4.10M(-41.4%) |
| Apr 1992 | -$4.10M(-36.7%) | - | - |
| Jan 1992 | - | -$500.00K(+66.7%) | -$2.90M(+14.7%) |
| Oct 1991 | - | -$1.50M(-87.5%) | -$3.40M(+2.9%) |
| Jul 1991 | - | -$800.00K(-700.0%) | -$3.50M(-16.7%) |
| Apr 1991 | -$3.00M(-328.6%) | -$100.00K(+90.0%) | -$3.00M(-3.4%) |
| Jan 1991 | - | -$1.00M(+37.5%) | -$2.90M(-52.6%) |
| Oct 1990 | - | -$1.60M(-433.3%) | -$1.90M(-533.3%) |
| Jul 1990 | - | -$300.00K | -$300.00K |
| Apr 1990 | -$700.00K | - | - |
FAQ
- What is Celldex Therapeutics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. annual cash from operations year-on-year change?
- What is Celldex Therapeutics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. quarterly cash from operations year-on-year change?
- What is Celldex Therapeutics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. TTM cash from operations year-on-year change?
What is Celldex Therapeutics, Inc. annual cash from operations?
The current annual cash from operations of CLDX is -$157.78M
What is the all-time high annual cash from operations for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high annual cash from operations is $27.00M
What is Celldex Therapeutics, Inc. annual cash from operations year-on-year change?
Over the past year, CLDX annual cash from operations has changed by -$50.49M (-47.06%)
What is Celldex Therapeutics, Inc. quarterly cash from operations?
The current quarterly cash from operations of CLDX is -$44.01M
What is the all-time high quarterly cash from operations for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high quarterly cash from operations is $37.09M
What is Celldex Therapeutics, Inc. quarterly cash from operations year-on-year change?
Over the past year, CLDX quarterly cash from operations has changed by -$14.68M (-50.05%)
What is Celldex Therapeutics, Inc. TTM cash from operations?
The current TTM cash from operations of CLDX is -$186.19M
What is the all-time high TTM cash from operations for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high TTM cash from operations is $35.12M
What is Celldex Therapeutics, Inc. TTM cash from operations year-on-year change?
Over the past year, CLDX TTM cash from operations has changed by -$64.70M (-53.25%)